River Stone Biotech ApS
Private limited companyCVR 39126729København ØActive
River Stone Biotech ApS is a private limited company, based in København Ø, active in research and experimental development on natural sciences and engineering, founded in 2017. The company made a loss in both 2024 and 2025, most recently DKK 31.2m. With 32 employees, the company is about 6 times larger than the industry median. Equity fell to DKK 7.8m in 2025.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit fell 63% (2024 → 2025), to DKK 1.2m.
- The loss got smaller: from DKK 44.6m to DKK 31.2m (2024 → 2025).
- Equity fell 26% (2024 → 2025), to DKK 7.8m.
Registrations, last 24 months
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 2,477 | 7,577 | 7,308 | 3,445 | 3,192 | 1,169 | −63.4% |
| Profit before tax | – | – | – | – | −50,073 | −36,705 | +26.7% |
| Net profit | −16,064 | −18,793 | −52,037 | −72,440 | −44,573 | −31,205 | +30% |
| Total assets | 13,106 | 18,628 | 24,934 | 22,441 | 15,360 | 11,793 | −23.2% |
| Equity | 8,948 | −9,845 | 10,693 | 14,828 | 10,603 | 7,828 | −26.2% |
| Liabilities | 4,157 | 28,472 | 14,241 | 7,613 | 4,757 | 3,965 | −16.6% |
| Cash and cash equivalents | 2,280 | 1,731 | 6,233 | 7,630 | 3,108 | 2,100 | −32.4% |
| Average number of employees | 15 | 18 | 22 | 22 | 23 | 25 | +8.7% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLoss for 6 years in a row
Net result has been negative in 2020–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 18/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 13/05/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 01/07/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 14/07/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 20/07/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 12/05/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with 20–49 employees9,922 companies in the comparison | No. 9,409of 9,892 Better than 5% | No. 3,659of 9,922 Better than 63% |
| Same industry and 20–49 employees64 companies in the comparison | No. 41of 62 Better than 34% | No. 44of 64 Better than 32% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 21,991of 33,588 Better than 35% | No. 4,430of 33,687 Better than 87% |
| All companies of type ApS66,508 companies in the comparison | No. 40,375of 66,379 Better than 39% | No. 8,182of 66,505 Better than 88% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- River Stone Biotech ApSDKK 1.2m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- River Stone Biotech ApS−DKK 31.2m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- River Stone Biotech ApSDKK 7.8m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- River Stone Biotech ApS32
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- River Stone Biotech Inc.100%
Management
3 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Jørgen Hansen | CEO | 21/12/2018 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Jørgen Hansen | Board member | 21/12/2018 |
| Paul D. Goldenheim | Board member | 21/12/2018 |
- Founders
- River Stone Biotech Inc.
Former management (1)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Paul D. Goldenheim | Director | 30/11/2017 | 21/12/2018 |
Signing rule: Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem.
Address and production units
1 active production unitsFruebjergvej 3
2100 København Ø
København Municipality · Postcode 2100
Other companies at the address (8)
- Vektor Ejendomme A/SBuying and selling of own real estate
- Symbion A/SRenting of commercial property
- Synopsys Denmark ApSComputer consultancy and computer facilities management
- Mequ A/SManufacture of medical and dental instruments and supplies
- Clinical-Microbiomics A/SResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| River Stone Biotech ApS | Fruebjergvej 3, 2100 København Ø | 37 | 1023080229 |
Purpose
Selskabets formål er forskning, udvikling og kommercialisering af lægemidler.
The purpose is quoted from the register in Danish.
Changes year by year
17 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20252 changesaccounts 1 · industry 1
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
- AccountsAnnual report for 2023 published
20231 changeaccounts 1
- AccountsAnnual report for 2022 published
20221 changeaccounts 1
- AccountsAnnual report for 2021 published
20211 changeaccounts 1
- AccountsAnnual report for 2020 published
20201 changecapital 1
- CapitalShare capital changed from 51,000 DKK to 52,000 DKK
20191 changecapital 1
- CapitalShare capital changed from 50,000 DKK to 51,000 DKK
20185 changesmanagement 4 · address 1
- ManagementJørgen Hansen appointed ceo
- ManagementJørgen Hansen appointed board member
- ManagementPaul D. Goldenheim appointed board member
- ManagementPaul D. Goldenheim stepped down as director
- AddressMoved to Fruebjergvej 3, 2100 København Ø
20173 changesfounded 1 · management 1 · ownership 1
- FoundedRegistered as River Stone Biotech ApS
- ManagementPaul D. Goldenheim appointed director
- OwnershipRiver Stone Biotech Inc. registered as owner (100%)
Related companies
Same industry in København
- Genmab A/S676 employees
- 3shape A/S518 employees
- Carlsberg A/S107 employees
- IQVIA RDS Denmark A/S100 employees
- Nuevolution A/S100 employees
- Sunshine Enterprise Holding A/S73 employees
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.